Bibliography
- Ranganath LR, Cox TF. Natural history of alkaptonuria revisited: analyses based on scoring systems. J Inherit Metab Dis 2011;34:1141-51
- Cox TF, Ranganath L. A quantitative assessment of alkaptonuria: Testing the reliability of two disease severity scoring systems. J Inherit Metab Dis 2011;34:1153-62
- O”Brien WM, La Du BN, Bunim JJ. Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis and ochronotic arthropathy: review of world literature (1584–1962). Am J Med 1963;34:813-38
- Phornphutkul C, Introne WJ, Perry MB, et al. Natural history of alkaptonuria. N Engl J Med 2002;347:2111-21
- Helliwell TR, Gallagher JA, Ranganath L. Alkaptonuria - a review of surgical and autopsy pathology. Histopathol 2008;53:503-12
- Suwannarat P, O”Brien K, Perry MB, et al. Use of nitisinone in patients with alkaptonuria. Metabol Clin Exper 2005;54:719-28
- Garrod AE. The Croonian lectures on inborn errors of metabolism. Lecture II. Alkaptonuria. Lancet 1908;2:73-9
- La Du BN, Zannoni VG, Laster L, et al. The nature of the defect in tyrosine metabolism in alcaptonuria. J Biol Chem 1958;230:251-60
- Pollak MR, Chou YH, Cerda JJ, et al. Homozygosity mapping of the gene for alkaptonuria to chromosome 3q2. Nat Genet 1993;5:201-4
- Fernandez-Canon JM, Granadino B, Beltrán-Valero de Bernabé D, et al. The molecular basis of Alkaptonuria. Nat Genet 1996;14:19-24
- Granadino B, Beltran-Valero de Bernabe D, Fernandez-Canon JM, et al. The human homogentisate 1,2 dioxigenase (HGO) gene. Genomics 1997;43:115-22
- Titus GP, Mueller CR, Burgner J, et al. Crystal structure of human homogentisate dioxygenase. Nat Struct Biol 2000;7:542-6
- La Du BN, Zannoni VG, Laster L, et al. The nature of the defect in tyrosine metabolism in alcaptonuria. J Biol Chem 1958;230:251-60
- Zannoni VG, Lomtevas N, Goldfiner S. Oxidation of homogentisic acid to ochronotic pigment in connective tissue. Biochim Biophys Acta 1969;177:94
- Keller JM, Macaulay W, Nercessian OA, et al. New developments in ochronosis: review of the literature. Rheumatol Int 2005;25:81-5
- Taylor AM, Boyde A, Wilson PJ, et al. The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria. Arthritis Rheum 2011;63:3887-96
- Zibolen M, Srsnova K, Srsen S. Increased urolithiasis in patients with alkaptonuria in childhood. Clin Genet 2000;58:79-80
- Venkataseshan VS, Chandra B, Graziano J, et al. Alkaptonuria and renal failure: a case report and review of the literature. Mod Pathol 1992;5:464-71
- Krizek V. Urolithiasis and prostatolithiasis in alcaptonuria with ochronosis. Int Urol Nephrol 1971;3:245-50
- Bulow C, Rosenberg J. Intrahepatic gallstones in patient with alkaptonuria. Ugeskr Laeger 2009;171:2198-9
- Taylor AM, Wilson PJ, Ingrams DR, et al. Calculi and intracellular ochronosis in the submandibular tissues from a patient with alkaptonuria. J Clin Pathol 2010;63:186-8
- Introne WJ, Phornphutkul C, Bernardini I, et al. Exacerbation of the ochronosis of Alkaptonuria due to renal insufficiency and improvement after renal transplantation. Mol Genet Metab 2002;77:136-42
- Mullan A, Cocker D, Taylor G, et al. Fatal oxidative haemolysis and methaemoglobinaemia in a patient with alkaptonuria and acute kidney injury. Clin Kidney J 2015;8(1):109-12
- Heng AE, Courbebaisse M, Kemeny JL, et al. Hemolysis in a patient with alkaptonuria and chronic kidney failure. Am J Kidney Dis 2010;56:1-4
- Abreo K, Abreo F, Zimmerman SW, et al. A fifty-year-old man with skin pigmentation, arthritis, chronic renal failure and methemoglobinaemia. Amer J Med Genet 1983;14:97-114
- Essalmi L, Roncato M, Mermet I, et al. [Bluish-brown sclera and ears]. Rev Med Int 2007;28:42-3
- Ranganath LR, Jarvis JC, Gallagher JA. Recent advances in management of alkaptonuria. J Clin Pathol 2013;66:367-73
- Festen JJ, Bouman JG, Nienhuis RL. Alkaptonuria, ochronosis and degenerative disorders of the spinal column and joints. Ned Tijdschr Geneeskd 1968;112:1575-85
- Parambil JG, Daniels CE, Zehr KJ, et al. Alkaptonuria diagnosed by flexible bronchoscopy. Chest 2005;128:3678-80
- Emel E, Karagoz F, Aydin IH, et al. Alkaptonuria with lumbar disc herniation: a report of two cases. Spine 2000;25:2141-4
- Akeda K, Kasai Y, Kawakita E, et al. Thoracic myelopathy with Alkaptonuria. Spine 2008;33:E62-5
- Rubeli M, Grob D. Lumbar spinal stenosis in systemic diseases and in hereditary syndromes. Orthopade 1993;22:250-6
- Farzannia A, Shokouhi G, Hadidchi S. Alkaptonuria and lumbar disc herniation. Report of three cases. J Neuros 2003;98:87-9
- Ogata J, Tamura K, Miyanishi K, et al. Anesthesia in a patient with alkaptonuric ochronosis for total hip arthroplasty. Masui 2008;57:439-42
- Araki K, Sudo A, Hasegawa M, et al. Devastating ochronotic arthropathy with successful bilateral hip and knee arthroplasties. J Clin Rheumatol 2009;15:138-40
- Aquaron R. Alkaptonuria: a very rare metabolic disorder. Indian J Biochem Biophys 2013;50:339-44
- Kalevski SK, Haritonov DG, Peev NA. Alcaptonuria with lumbar disc prolapse: case study and review of the literature. Spine J 2007;7:495-8
- Ladjouze-Rezig A, Rodriguez de Cordoba S, Aquaron R. Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies--a case study of 14 patients in 11 families. Joint Bone Spine 2006;73:284-92
- Manoj Kumar RV, Rajasekaran S. Spontaneous tendon ruptures in Alkaptonuria. J Bone Joint Surg Br 2003;85:883-6
- Chua SY, Chang HC. Bilateral spontaneous rupture of the quadriceps tendon as an initial presentation of alkaptonuria--a case report. Knee 2006;13:408-10
- Fisher AA, Davis MW. Alkaptonuric ochronosis with aortic valve and joint replacements and femoral fracture: a case report and literature review. Clin Med Res 2004;2:209-15
- Wilke A, Steverding D. Ochronosis as an unusual cause of valvular defect: a case report. J Med Case Reports 2009;3:9302
- Pettit SJ, Fisher M, Gallagher JA, et al. Cardiovascular manifestations of Alkaptonuria. J Inherit Metab Dis 2011;34:1177-81
- Kragel AH, Lapa JA, Roberts WC. Cardiovascular findings in alkaptonuric ochronosis. Am Heart J 1990;120:1460-3
- Brueck M, Bandorski D, Kramer W, et al. Aortic valve stenosis due to alkaptonuria. J Heart Valve Dis 2008;17:127-9
- Sanji RR, Reddy KE, Channegowda C. Alkaptonuria: Otolaryngologic clues to diagnosis. Indian J Otol 2011;17:22-5
- Srsen S, Vondracek J, Srsnova K, et al. Analysis of the life span of alkaptonuric patients. Cas Lek Cesk 1985;124:1288-91
- Montagutelli X, Lalouette A, Coudé M, et al. AKU, a mutation of the mouse homologous to human alkaptonuria, maps to chromosome 16. Genomics 1994;19:9-11
- Taylor AM, Preston AJ, Paulk NK, et al. Ochronosis in a murine model of alkaptonuria is synonymous to that in the human condition. Osteoarthritis Cartilage 2012;20:880-6
- Preston AJ, Keenan CM, Sutherland H, et al. Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone. Ann Rheum Dis 2014;73:284-9
- Olah AV, Llyes I, Szoke A, et al. Urinary homogentisic acid in alkaptonuric and healthy children. Clin Chem Lab Med 2003;41:356-9
- Usher JL, Ascher DB, Pires DE, et al. Analysis of HGD gene mutations in patients with alkaptonuria from the United Kingdom: Identification of Novel Mutations. JIMD Rep 2015. [Epub ahead of print]
- Whybra C, Kampmann C, Krummenauer F, et al. The mainz severity score index: a new instrument for quantifying the anderson-fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 2004;65:299-307
- Sagit M, Uludag M, San I. An unusual dark pigmentation on the tympanic membrane. J Laryngol Otol 2011;125:1059-61
- Pau HW. Involvement of the tympanic membrane and ear ossicle system in ochronotic alkaptonuria. Laryngol Rhinol Otol (Stuttg) 1984;63:541-4
- Kovacevic M, Simic O, Medved I, et al. Ochronosis of aortic valve and aorta. J Heart Valve Dis 2006;15:730-2
- Reddy OJ, Gafoor JA, Suresh B, et al. Alkaptonuria with review of literature. J NTR Univ Health Sci 2014;3:125-9
- Mahesh DV, Gunnaiah DC, Chandar V. A rare case of alkaptonuria - achilles tendon rupture. IJHSR 2014;4:323-7
- Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res 1992;7:137-45
- Guglielmi G, Grimston SK, Fischer KC, et al. Osteoporosis: diagnosis with lateral and posteroanterior dual x-ray absorptiometry compared with quantitative CT. Radiology 1994;192:845-50
- Salaffi F, Carotti M, Garofalo G, et al. Radiological scoring methods for ankylosing spondylitis: a comparison between the Bath Ankylosing Spondylitis Radiology Index and the modified Stoke Ankylosing Spondylitis Spine Score. Clin Exp Rheumatol 2007;25:67-74
- Ramiro S, van Tubergen A, Stolwijk C, et al. Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke ankylosing spondylitis spine score (mSASSS) or the radiographic ankylosing spondylitis spinal score (RASSS)? Arthritis Res Ther 2013;15:R14
- Brandt KD, Fife RS, Braunstein EM, et al. Radiographic grading of the severity of knee osteoarthritis: relation of the Kellgren and Lawrence grade to a grade based on joint space narrowing, and correlation with arthroscopic evidence of articular cartilage degeneration. Arthritis Rheum 1991;34:1381-6
- McAlindon TE, Watt I, McCrae F, et al. Magnetic resonance imaging in osteoarthritis of the knee: correlation with radiographic and scintigraphic findings. Ann Rheum Dis 1991;50:14-19
- Terjesen T, Gunderson RB. Radiological evaluation of osteoarthritis of the hip. Acta Orthop 2012;83:185-9
- Roemer FW, Hunter DJ, Winterstein A, et al. Hip Osteoarthritis MRI Scoring System (HOAMS): reliability and associations with radiographic and clinical findings. Osteoarthritis Cartilage 2011;19:946-62
- Kamishima T, Kato M, Atsumi T, et al. Contrast-enhanced whole body joint MR imaging in rheumatoid patients on tumour necrosis factor-alpha agents: a pilot study to evaluate novel scoring system for MR synovitis. Clin Exp Rheumatol 2013;31:154
- Rennie WJ. Clinical examination or whole-body magnetic resonance imaging: the Holy Grail of spondyloarthritis imaging. Arthritis Res Ther 2012;14:110
- Bhargava P, Hanif M, Nash C. Whole-body F-18 sodium fluoride PET-CT in a patient with renal cell carcinoma. Clin Nucl Med 2008;33:894-5
- Vinjamuri S, Ramesh CN, Jarvis J, et al. Nuclear medicine techniques in the assessment of alkaptonuria. Nucl Med Commun 2011;32:880-6
- Omoumi P, Mercier GA, Lecouvet F, et al. CT Arthrography, MR Arthrography, PET, and Scintigraphy in Osteoarthritis. Radiol Clin North Am 2009;47:595-615
- Genovese F, Siebuhr AS, Musa K, et al. Investigating the robustness and diagnostic potential of extracellular matrix remodelling biomarkers in alkaptonuria. JIMD Rep 2015. [Epub ahead of print]
- Valenzuela R, Cooperrider PA, Gogate P, et al. Relapsing polychondritis. Immunomicroscopic findings in cartilage of ear biopsy specimens. Hum Pathol 1980;11:19-22
- Tinti L, Taylor AM, Santucci A, et al. Development of an in vitro model to investigate joint ochronosis in alkaptonuria. Rheumatology (Oxford) 2011;50:271-7
- Watts RW, Watts RA. Alkaptonuria: a 60-yr follow-up. Rheumatology 2007;46:358-9
- Hamamy H. Consanguineous marriages. J Community Genetics 2012;3:185-92
- Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22
- Cannon CP, Giugliano RP, Blazing MA, et al. Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes. Am Heart J 2008;156:826-32
- Introne WJ, Perry MB, Troendle J, et al. A 3-year randomized therapeutic trial of nitisinone in Alkaptonuria. Mol Genet Metab 2011;103:307-14
- Keenan CM, Preston A, Sutherland H, et al. Nitisinone arrests but does not reverse ochronosis in alkaptonuric mice. JIMD Rep 2015; Epub ahead of print
- Thompson GR. Towards a new era: is coronary artery disease reversible? Cardiology 1990;77(Suppl 4):66-9
- Beck M. The Mainz Severity Score Index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease. Acta Pædiatrica Suppl 2006;451:43-6
- Lock E, Ranganath LR, Timmis O. The role of nitisinone in tyrosine pathway disorders. Curr Rheumatol Rep 2014;16:457
- Stewart RM, Briggs MC, Jarvis JC, et al. Reversible keratopathy due to hypertyrosinaemia following intermittent low-dose nitisinone in alkaptonuria: a case report. JIMD Rep 2014; Epub ahead of print
- Cerone R, Holme E, Sciaffino MC, et al. Tyrosinaemia type III: diagnosis and 10-year follow-up. Acta Paediat 1997;86:1013-15
- Willis MS, Basinger AA, Fan Z, et al. Hepatosplenomegaly in an 8-month-old child. Labmedicine 2006;37:665-95
- de Laet C, Dionisi-Vici C, Leonard JV, et al. Recommendations for the management of tyrosinaemia type 1. Orphanet J Rare Dis 2013;8:8
- McKiernan PJ. Nitisinone in the treatment of hereditary tyrosinaemia type I. Drugs 2006;66:743-50
- Mayorandan S, Meyer U, Gokcay G, et al. Cognitive impairment Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice. Orphanet J Rare Dis 2014;9:107